HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection

Tissue Antigens

Volumn 55, Issue 3, 2000, Pages 195-198

  Nieto, A ^a   Beraun Y ^a   Callado, M D ^a   Caballero, A ^b   Alonso, A ^b   Gonzalez A ^a   Martín, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Chagas' disease; HLA haplotypes; Trypanosoma cruzi

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDEMIC DISEASE; GENETIC POLYMORPHISM; HAPLOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; PERU; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ADOLESCENT; ADULT; AGED; ANIMALS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; CHRONIC DISEASE; DISEASE SUSCEPTIBILITY; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MIDDLE AGED; PERU; POLYMORPHISM, GENETIC; TRYPANOSOMA CRUZI;

ANIMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0034013643     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.550301.x     Document Type: Article

References (23)

1. 1. Kirchhoff LV. American trypanosomiasis (Chagas' disease). A tropical disease now in the United States. N Engl J Med 1993: 329: 639-44.
2. 2. WHO.. Control of Chagas disease. Report of a WHO expert committee. World Health Organization, Technical report series 811. Geneva: WHO, 1991: 47.
3. 3. Kalil J, Cunha-Neto E. Autoimmunity in Chagas disease cardiomyopathy. Fulfilling the criteria at last? Parasitol Today 1996: 12: 396-9.
4. 4. Williams-Blangero S, Vandeberg JL, Blangero J, Teixeira ARL. Genetic epidemiology of seropositivity for Trypanosoma cruzi infection in rural Goias, Brazil. Am J Trop Med Hyg 1997:57:538-43.
5. 5. Wrightsman R, Krassner SM, Whatson JD, Manning JE. Role of the H-2s haplotype in survival of mice after infection with Trypanosoma cruzi. Infect Immun 1984:44: 351-4.
6. 6. Klein J, Satta Y, O'hUigin C, Takahata N. The molecular descent of the major histocompatibility complex. Annu Rev Immunol 1993: 11: 269-96.
7. 7. Hill AVS. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998: 16: 593-617.
8. 8. Rothhammer F, Allison M, Núñez L, Standen V, Arriaza B. Chagas' disease in pre-Columbian South American. Am J Phy Antropol 1985: 68: 495-8.
9. 9. Mota EA, Guimaraes AC, Santana OO, Sherlock II, Hoff R, Weller TH. A nine-year prospective study of Chagas' disease in a defined rural population in Northeast Brazil. Am J Trop Med Hyg 1990: 42: 429-40.
10. 10. Nieto A, Tobes R, Martin J, Pareja E. Allele walking: a new and highly accurate approach to HLA-DRB1 typing. Application to DRB1*04 alleles. Tissue Antigens 1997: 49: 141-51.
11. 11. Begovich AB, McClure GR, Suraj VC et al. Polymorphism, recombination and linkage disequilibirum within the HLA class II region. J Immunol 1992: 148: 249-58.
12. 12. Trachtenberg EA, Erlich O, Rickards O, DeStefano GF, Klitz W. HLA class II linkage disequilibrium and haplotype evolution in the Cayapa Indians of Ecuador. Am J Hum Genet 1995: 57: 415-24.
13. 13. Tiwari JL, Terasaki PI. HLA and disease associations. New York: Springer-Verlag, 1985.
14. 14. Hill AVS, Allsopp CEM, Kwiatkowski D et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991: 352: 595-600.
15. 15. Degli-Esposti MA, Leaver AL, Christiansen FT, Wirt CS, Abraham LJ, Dawkins RL. Ancestral haplotypes: Conserved population MHC haplotypes. Hum Immunol 1992: 34: 242-5.
16. 16. Janeway CA, Travers P. Host defense against infection. In: Janeway CA, Travers P, eds. Immunobiology. The immune system in health and disease. 3rd ed. London: Current Biology Ltd., 1997: 9:1-9:52.
17. 17. Gruen JR, Weismann SM. Evolving views of the Major Histocompatibility complex. Blood 1997: 90: 4252-65.
18. 18. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996: 272: 50-4.
19. 19. Murray JS. How the MHC selects Th1/Th2 immunity. Immunol Today 1998: 19:157-63.
20. 20. Gómez LE, Nasser JR, Basombrío MA. Complete immunization against Trypanosoma cruzi verified in individual mice by complement-mediated lysis. Mem Inst Oswaldo Cruz 1996: 91: 56-61.
21. 21. Deghaide NHS, Dantas RO, Donadi EA. HLA class I and class II profiles of patients presenting with Chagas' disease. Dig Dis Sci 1998: 2: 246-52.
22. 22. Fernández-Mestre MT, Layrisse Z, Montagnani S et al. Influence of the HLA class II polymorphism in chronic Chagas' disease. Parasite Immunol 1998: 20: 197-203.
23. 23. Llop E, Rothhammer F, Acuña M, Apt W. HLA antigens in cardiomyopathic Chilean chagasics. Am J Hum Genet 1988: 43: 770-3.